Physician profile

Jeff Choi

Stanford, CA

NPI 1992239446

$1,117.93

in general payments reported to CMS, 2019-2025

5 companies · $116 in 2025

The $116 reported for 2025 was less than what a typical provider received nationally.

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$500.00
Food and Beverage$264.55

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Moon Surgical $500.00 2024 Maestro System
Medtronic, INC. $240.60 2021
Stryker Corporation $148.16 2024 Prolift
Janssen Pharmaceuticals, INC $116.39 2025 Spravato
Abbvie INC. $112.78 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jeff Choi

$1,117.93

in general payments reported 2019-2025

Years
2021-2025
Top company
Moon Surgical
Context
The $116 reported for 2025 was less than what a typical provider received nationally.

https://glasscript.com/doctor/11300497/jeff-choi

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.